RBL LLC Launches SteerBio, Pioneering Therapy for Lymphedema with $18.2 Million Federal Funding RBL LLC's new spin-off, SteerBio, has launched with $18.2 million in federal funding for a novel therapy targeting lymphedema, aiming to change patient lives.

RBL LLC Launches SteerBio, Pioneering Therapy for Lymphedema with $18.2 Million Federal Funding #USA #Houston #Lymphedema #RBL_LLC #SteerBio